Sign In

Login

Password

Forgot Password ? Sign Up

CD19 (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD19" in Czech language version.

refsWebsite
Global rank Czech rank
8doi.org
2nd place
4th place
6worldcat.org
5th place
3rd place
4nih.gov
4th place
8th place
2annualreviews.org
3,867th place
1,555th place
1archive.org
6th place
10th place
1biomedcentral.com
2,747th place
459th place
1embopress.org
low place
low place
1jci.org
low place
7,867th place
1nejm.org
2,374th place
1,252nd place
1springer.com
274th place
174th place
1elsevier.com
610th place
203rd place

annualreviews.org

archive.org

biomedcentral.com

ehoonline.biomedcentral.com

doi.org

  • HARWOOD, Naomi E.; BATISTA, Facundo D. Early Events in B Cell Activation. Annual Review of Immunology. 2010-03-01, roč. 28, čís. 1, s. 185–210. Dostupné online [cit. 2024-02-16]. ISSN 0732-0582. doi:10.1146/annurev-immunol-030409-101216. (anglicky) 
  • FEARON, Douglas T.; CARROLL, Michael C.; CARROLL, Michael C. Regulation of B Lymphocyte Responses to Foreign and Self-Antigens by the CD19/CD21 Complex. Annual Review of Immunology. 2000-04, roč. 18, čís. 1, s. 393–422. Dostupné online [cit. 2024-02-16]. ISSN 0732-0582. doi:10.1146/annurev.immunol.18.1.393. (anglicky) 
  • WANG, Kemeng; WEI, Guoqing; LIU, Delong. CD19: a biomarker for B cell development, lymphoma diagnosis and therapy. Experimental Hematology & Oncology. 2012-12, roč. 1, čís. 1. Dostupné online [cit. 2024-02-16]. ISSN 2162-3619. doi:10.1186/2162-3619-1-36. PMID 23210908. (anglicky) 
  • NUTT, S. L. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. The EMBO Journal. 1998-04-15, roč. 17, čís. 8, s. 2319–2333. Dostupné online [cit. 2024-02-16]. doi:10.1093/emboj/17.8.2319. PMID 9545244. 
  • CHUNG, Elaine Y.; PSATHAS, James N.; YU, Duonan. CD19 is a major B cell receptor–independent activator of MYC-driven B-lymphomagenesis. Journal of Clinical Investigation. 2012-06-01, roč. 122, čís. 6, s. 2257–2266. Dostupné online [cit. 2024-02-16]. ISSN 0021-9738. doi:10.1172/JCI45851. PMID 22546857. (anglicky) 
  • VAN ZELM, Menno C.; REISLI, Ismail; VAN DER BURG, Mirjam. An Antibody-Deficiency Syndrome Due to Mutations in the CD19 Gene. New England Journal of Medicine. 2006-05-04, roč. 354, čís. 18, s. 1901–1912. Dostupné online [cit. 2024-02-16]. ISSN 0028-4793. doi:10.1056/NEJMoa051568. (anglicky) 
  • ZINZANI, Pier Luigi; MINOTTI, Giorgio. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology. 2022-01, roč. 148, čís. 1, s. 177–190. Dostupné online [cit. 2024-02-16]. ISSN 0171-5216. doi:10.1007/s00432-021-03833-x. PMID 34741682. (anglicky) 
  • ABRAMSON, Jeremy S. Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma. Transfusion Medicine Reviews. 2020-01, roč. 34, čís. 1, s. 29–33. Dostupné online [cit. 2024-02-16]. doi:10.1016/j.tmrv.2019.08.003. (anglicky) 

elsevier.com

linkinghub.elsevier.com

  • ABRAMSON, Jeremy S. Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma. Transfusion Medicine Reviews. 2020-01, roč. 34, čís. 1, s. 29–33. Dostupné online [cit. 2024-02-16]. doi:10.1016/j.tmrv.2019.08.003. (anglicky) 

embopress.org

emboj.embopress.org

  • NUTT, S. L. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. The EMBO Journal. 1998-04-15, roč. 17, čís. 8, s. 2319–2333. Dostupné online [cit. 2024-02-16]. doi:10.1093/emboj/17.8.2319. PMID 9545244. 

jci.org

  • CHUNG, Elaine Y.; PSATHAS, James N.; YU, Duonan. CD19 is a major B cell receptor–independent activator of MYC-driven B-lymphomagenesis. Journal of Clinical Investigation. 2012-06-01, roč. 122, čís. 6, s. 2257–2266. Dostupné online [cit. 2024-02-16]. ISSN 0021-9738. doi:10.1172/JCI45851. PMID 22546857. (anglicky) 

nejm.org

  • VAN ZELM, Menno C.; REISLI, Ismail; VAN DER BURG, Mirjam. An Antibody-Deficiency Syndrome Due to Mutations in the CD19 Gene. New England Journal of Medicine. 2006-05-04, roč. 354, čís. 18, s. 1901–1912. Dostupné online [cit. 2024-02-16]. ISSN 0028-4793. doi:10.1056/NEJMoa051568. (anglicky) 

nih.gov

ncbi.nlm.nih.gov

  • WANG, Kemeng; WEI, Guoqing; LIU, Delong. CD19: a biomarker for B cell development, lymphoma diagnosis and therapy. Experimental Hematology & Oncology. 2012-12, roč. 1, čís. 1. Dostupné online [cit. 2024-02-16]. ISSN 2162-3619. doi:10.1186/2162-3619-1-36. PMID 23210908. (anglicky) 
  • NUTT, S. L. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. The EMBO Journal. 1998-04-15, roč. 17, čís. 8, s. 2319–2333. Dostupné online [cit. 2024-02-16]. doi:10.1093/emboj/17.8.2319. PMID 9545244. 
  • CHUNG, Elaine Y.; PSATHAS, James N.; YU, Duonan. CD19 is a major B cell receptor–independent activator of MYC-driven B-lymphomagenesis. Journal of Clinical Investigation. 2012-06-01, roč. 122, čís. 6, s. 2257–2266. Dostupné online [cit. 2024-02-16]. ISSN 0021-9738. doi:10.1172/JCI45851. PMID 22546857. (anglicky) 
  • ZINZANI, Pier Luigi; MINOTTI, Giorgio. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology. 2022-01, roč. 148, čís. 1, s. 177–190. Dostupné online [cit. 2024-02-16]. ISSN 0171-5216. doi:10.1007/s00432-021-03833-x. PMID 34741682. (anglicky) 

springer.com

link.springer.com

  • ZINZANI, Pier Luigi; MINOTTI, Giorgio. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology. 2022-01, roč. 148, čís. 1, s. 177–190. Dostupné online [cit. 2024-02-16]. ISSN 0171-5216. doi:10.1007/s00432-021-03833-x. PMID 34741682. (anglicky) 

worldcat.org